FindTrial
Sign In

A CLINICAL STUDY AMONG PATIENTS OF PRIMARY CUTANEOUS AMYLOIDOSIS REGARDING DISEASE SYMPTOMS AND ITS CAUSES USING SKIN BIOPSY RESULTS AND DERMOSCOPY

A CLINICO-EPIDEMIOLOGICAL STUDY AMONG PATIENTS OF PRIMARY CUTANEOUS AMYLOIDOSIS USING DERMOSCOPY AND HISTOPATHOLOGY IN A TERTIARY CARE INSTITUTE OF NORTH INDIA.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047739
Enrollment
52
Registered
2022-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E854- Organ-limited amyloidosis

Interventions

Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of both sexes (males and females), aged >18 years, 2.Patients who have clinical diagnosis of PCA. 3.Patients who have not taken any form of treatment for PCA. 4.Patients who are willing to sign the written consent form before participating in the study.

Exclusion criteria

Exclusion criteria: 1.Patients with systemic amyloidosis. 2.Patients who had taken any form of treatment for the disease. 3.Pregnant or lactating women or immunocompromised patients

Design outcomes

Primary

MeasureTime frame
To study the Dermoscopical Profile of Primary Cutaneous AmyloidosisTimepoint: At Baseline—

Secondary

MeasureTime frame
1)To study the clinico epidemiological profile of primary cutaneous amyloidosis. 2)To study the histopathological profile of primary cutaneous amyloidosis. 3)To correlate dermoscopical and histopathological profiles of primary cutaneous amyloidosis. Timepoint: All of Three at Base Line—

Countries

India

Contacts

Public ContactTEEKENDRA SINGH MEENA

AIIMS, BATHINDA

drshivani.derm@gmail.com8287020404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026